La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Chemomab Therapeutics a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Chemomab Therapeutics..

Chemomab Therapeutics (NASDAQ:CMMB) Azioni, Catena delle Opzioni

Chemomab Therapeutics

Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101 treating rare fibrotic conditions.

Chemomab Therapeutics Ltd. - American Depositary Shares

Chemomab Therapeutics Ltd

TD Cowen analyst Joshua Jennings initiates coverage on CeriBell (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CBLL#NASDAQ">CBLL</a>) with a Buy rating and announces Price Target of $31.

News

Price Target

Initiation

Analyst Ratings

CBLL

TD Cowen Initiates Coverage On CeriBell with Buy Rating, Announces Price Target of $31

B of A Securities analyst Ross Fowler upgrades Idacorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IDA#NYSE">IDA</a>) from Neutral to Buy and raises the price target from $113 to $117.

Upgrades

B of A Securities Upgrades Idacorp to Buy, Raises Price Target to $117

Contracts

RDWR

Radware Expands Customer Relationship With A Prominent US Based Communications Platform As A Service Provider In Multimillion-Dollar Deal

Emeren Enters Co-Development Agreement With Arpinge To Jointly Develop A 300 MW Battery Energy Storage System Portfolio In Southern Italy

Taiwan Semiconductor Manufacturing Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) remains vulnerable to Taiwan&#8217;s surging electricity prices, a shift that could impact the semiconductor industry.
Once a competitive edge, Taiwan&#8217;s low-cost energy has become more challenging to maintain, leading to increased costs for major industrial consumers, the Financial Times <a target="_blank" href="https://www.ft.com/content/cfd77e84-5d5b-47ae-96bd-9973b1c18662" rel="noreferrer noopener">reports</a>.
Taiwan Semiconductor now anticipates that electricity expenses in Taiwan will surpass those in its other significant locations, including the U.S., Japan, and Germany.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/24/10/41633790/apple-refreshes-macbook-pro-lineup-with-m4-pro-and-m4-max-3nm-chips" rel="noreferrer noopener">Apple Refreshes MacBook Pro Lineup With M4 Pro and M4 Max 3Nm Chips</a>
<a target="_blank" href="https://www.benzinga.com/markets/equities/24/11/41706702/nvidia-supplier-tsmc-to-double-advanced-chip-packaging-capacity-as-ai-demand-from-microsoft-amaz" rel="noreferrer noopener">Recent reports indicated</a> the chipmaker will double its advanced packaging capacity by 2025, largely to meet the rising demand for AI chips from major tech firms like Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) and Microsoft Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>). The company&#8217;s CoWoS packaging technology is in high demand, with Nvidia expected to use more than half of the expanded capacity.
CFO Wendell Huang recently disclosed to investors that power costs in Taiwan have effectively doubled over the past few years and will likely be Taiwan Semiconductor&#8217;s highest globally by 2024.
Taiwan&#8217;s government has raised electricity prices four times since 2022, with increases primarily affecting industrial users like Taiwan Semiconductor.
In line with its broader energy transition, Taiwan aims to boost renewable energy to supply up to 30% of its power by 2030. However, a recent emphasis on scaling back coal and nuclear power has made it increasingly challenging to meet industrial demands.
According to FT, Taiwan relies on coal and liquefied natural gas for over 80% of its energy supply, with renewable sources accounting for only 9.5%.
The rising electricity rates alone may not significantly hinder Taiwan Semiconductor&#8217;s operations, as power costs constitute a minor portion of its overall expenses. However, consistent supply disruptions could threaten Taiwan Semiconductor&#8217;s ability to expand its production capacity in Taiwan, FT writes.
Taiwan Semiconductor stock has gained 89% year-to-date. Investors can gain exposure to the stock through the iShares Semiconductor ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOXX#NASDAQ">SOXX</a>) and the First Trust NASDAQ Technology Dividend Index Fund (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TDIV#NASDAQ">TDIV</a>).
Price Actions:&nbsp;TSM stock traded higher by 1.17% to $193.80 premarket at the last check on Tuesday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/government/24/11/41726213/applied-materials-and-lam-research-shift-supply-chains-away-from-china-to-meet-new-us-guidelines" target="_blank" rel="noreferrer noopener">Applied Materials and Lam Research Shift Supply Chains Away from China to Meet New US Guidelines</a></li>
</ul>
Photo by wakamatsu.h via Shutterstock

Government

Regulations

Tech

Media

MSFT

NVDA

iShares PHLX SOX Semiconductor Sector Index Fund

SOXX

TDIV

Taiwan Semiconductor Faces Rising Energy Costs, Potential Outages Threaten Production

As the United States approaches the election, Trump Media &amp; Technology Group Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DJT#NASDAQ">DJT</a>) has seen a notable 5.15% increase in pre-market trading on Tuesday, as per <a href="https://pro.benzinga.com">Benzinga Pro</a>. This surge comes as traders perceive the company&#8217;s stock as a potential indicator of Donald Trump&#8217;s reelection chances.
What Happened: The recent uptick in Trump Media &amp; Technology Group&#8217;s stock is linked to the upcoming U.S. elections. On Monday, DJT closed 12.37% higher at $34.34.
Traders are treating Trump&#8217;s stock as a gauge for his reelection prospects. If Trump wins, his platform, Truth Social, is expected to play a significant role in his communication strategy, akin to his use of X during his presidency, according to <a href="https://www.cnbctv18.com/world/share-of-donald-trumps-social-media-firm-surge-on-eve-of-the-us-election-day-19503834.htm">CNBC</a>. However, if Vice President Kamala Harris wins, the future of Truth Social could face challenges.
See Also: <a href="https://www.benzinga.com/news/24/11/41710411/market-analyst-who-predicted-trumps-2016-win-and-bidens-2020-victory-now-sees-former-president-retak?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Market Analyst Who Predicted Trump&#8217;s 2016 Win And Biden&#8217;s 2020 Victory, Now Sees Former President Retaking The White House With &#8216;Large Majority Of Swing States&#8217;</a>
This development is occurring as the nation gears up for a pivotal election, with market participants closely watching political dynamics. The performance of Trump Media &amp; Technology Group&#8217;s stock reflects broader sentiments regarding the election&#8217;s potential outcomes and their implications for Trump&#8217;s media ventures.
Why It Matters: The election race between Trump and Harris has tightened, with recent polls showing <a href="https://www.benzinga.com/general/politics/24/11/41733277/harris-vs-trump-vice-president-has-two-point-lead-in-final-election-poll-swing-states-remain-clo">Harris maintaining a slight lead</a> over Trump. However, her lead has been shrinking, indicating a closely contested election. This uncertainty adds to the volatility surrounding Trump Media &amp; Technology Group&#8217;s stock.
Additionally, options activity for <a href="https://www.benzinga.com/insights/options/24/11/41717863/this-is-what-whales-are-betting-on-trump-media-technology">Trump Media &amp; Technology</a> has seen significant movement, with deep-pocketed investors showing a divided sentiment. While 36% of these investors are bullish, 48% are bearish, indicating mixed expectations about the company&#8217;s future. 
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/asia/24/11/41722178/if-trump-and-republicans-sweep-dollar-may-climb-7-but-harris-win-could-bring-5-drop-says-jpmorgan?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">If Trump And Republicans Sweep, Dollar May Climb 7% — But Harris Win Could Bring 5% Drop, Says JPMorgan</a></li>
</ul>
Disclaimer: This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.
Image via Shutterstock

Equities

Pre-Market Outlook

Markets

General

Trump Media (DJT) Stock Rises Over 6% In Pre-Market Ahead Of Presidential Election Eve

Vishay Precision Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VPG#NYSE">VPG</a>) sees Q4 sales of $70.000 million-78.000 million vs $79.10 million estimate.

Guidance

Vishay Precision Group Sees Q4 Sales $70.000M-78.000M vs $79.10M Est

TD Cowen analyst Bill Katz downgrades Affiliated Managers Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMG#NYSE">AMG</a>) from Buy to Hold and lowers the price target from $226 to $177.

Downgrades

TD Cowen Downgrades Affiliated Managers Group to Hold, Lowers Price Target to $177

Vishay Precision Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VPG#NYSE">VPG</a>) reported quarterly earnings of $0.19 per share which missed the analyst consensus estimate of $0.26 by 26.92 percent. This is a 59.57 percent decrease over earnings of $0.47 per share from the same period last year. The company reported quarterly sales of $75.73 million which missed the analyst consensus estimate of $76.71 million by 1.28 percent. This is a 11.80 percent decrease over sales of $85.85 million the same period last year.

Earnings

Earnings Misses

Vishay Precision Group Q3 Adj $0.19 Misses $0.26 Estimate, Sales $75.73M Miss $76.71M Estimate

CRVL

CorVel Q2 EPS $1.35 Up From $1.15 YoY, Sales $224M Up From $196M YoY

Deutsche Bank analyst Bryan Keane downgrades Marqeta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MQ#NASDAQ">MQ</a>) from Buy to Hold and lowers the price target from $9 to $4.

Deutsche Bank Downgrades Marqeta to Hold, Lowers Price Target to $4

BTIG analyst Sean Lavin downgrades Tactile Systems Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCMD#NASDAQ">TCMD</a>) from Buy to Neutral.

TCMD

BTIG Downgrades Tactile Systems Tech to Neutral

INGR

Ingredion Now Expects FY24 Net Sales To Be Down Mid-Single-Digits (Prior View: Down Low Single-Digits), Excluding Effects Of Sale Of South Korea Business

Ingredion Raises FY24 Adjusted EPS Outlook From $9.70 - $10.20 To $10.35 - $10.65, Est $9.97

2024 Financial Guidance
The Company is updating certain metrics for its full-year 2024 guidance, as detailed in the table below:
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1">Financial Metric</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">Prior FY 2024 Guidance</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">Updated FY 2024 Guidance</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Revenues</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$935 million to $955 million</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$930 million to $940 million</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Adjusted EBITDA</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$580 million to $595 million</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$580 million to $590 million</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Interest expense</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$320 million to $330 million</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">(unchanged)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Cash flow from operations</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$135 million to $150 million</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$135 million to $145 million</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Capital expenditures</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$120 million to $130 million</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">(unchanged)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Depreciation</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$80 million to $90 million</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">(unchanged)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Amortization of intangible assets</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$345 million to $350 million</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">(unchanged)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Effective tax rate</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">25% to 28%</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">(unchanged)</td>
</tr>
</tbody>
</table>
</figure>

Health Care

MPLN

MultiPlan Expects 2024 Revenues Of $930M-$940M Compared With Prior Guidance $935M-$955M And Consensus Of $939.207M

Patria Investments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAX#NASDAQ">PAX</a>) reported quarterly earnings of $0.23 per share which missed the analyst consensus estimate of $0.24 by 4.17 percent. This is unchanged from the same period last year. The company reported quarterly sales of $77.700 million which beat the analyst consensus estimate of $76.058 million by 2.16 percent. This is a 25.93 percent increase over sales of $61.700 million the same period last year.

Earnings Beats

Patria Investments Q3 2024 Adj. EPS $0.23 Misses $0.24 Estimate, Sales $77.700M Beat $76.058M Estimate

Bernstein analyst Nikhil Devnani upgrades eBay (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EBAY#NASDAQ">EBAY</a>) from Market Perform to Outperform and announces $70 price target.

EBAY

Bernstein Upgrades eBay to Outperform, Announces $70 Price Target

2024 Financial Guidance
<ul>
<li>2024 total sales growth is now expected to be 4% to 5% over 2023, compared with prior guidance of 4% to 6% growth.</li>
<li>2024 non-GAAP diluted EPS attributable to Henry Schein, Inc. is now expected to be $4.74 to $4.82, compared with prior guidance of $4.70 to $4.82, and reflects growth of 5% to 7% compared with 2023 non-GAAP diluted EPS of $4.50.</li>
<li>2024 Adjusted EBITDA is expected to grow in the low-double-digit percentages versus 2023 Adjusted EBITDA, and is unchanged compared to prior guidance.</li>
</ul>

HSIC

Henry Schein Expects 2024 Adjusted EPS Of $4.74 To $4.82 Compared With Prior Guidance Of $4.70-$4.82 And Consensus Of $4.75

On Monday, November 4th, U.S. markets closed lower after a volatile session as investors braced for a pivotal week with the U.S. presidential election and the Federal Reserve&#8217;s policy announcement. A poll showing Kamala Harris leading in Iowa impacted &#8220;Trump trades,&#8221; adding market uncertainty amid expectations of delayed election results.
Economic data showed that U.S. factory orders dropped by 0.5% in September, reaching $584.2 billion, following a revised 0.8% decrease in August.
Most S&amp;P 500 sectors closed lower, led by losses in utilities, communication services, and financials, while energy and real estate stocks rose.
The Dow Jones Industrial Average dipped 0.61% to close at 41,794.60, the S&amp;P 500 fell 0.28% to 5,712.69, and the Nasdaq Composite declined 0.33% to finish at 18,179.98.
Asia Markets Today
<ul>
<li>On Tuesday, Japan&#8217;s Nikkei 225 gained 1.42% and ended the session at 38,595.50, led by gains in the Glass, Transportation Equipment, and Banking sectors.</li>
<li>Australia&#8217;s S&amp;P/ASX 200 declined 0.40% and ended the day at 8,131.80, led by losses in the Gold, Utilities, and Financial sectors.</li>
<li>India&#8217;s Nifty 50 traded higher by 0.85% at 24,199.05, and Nifty 500 was up 0.63% at 22,661.00, led by gains in the Metals, Banking, and Oil &amp; Gas sectors shares.</li>
<li>China&#8217;s Shanghai Composite rose 2.32% to close at 3,386.99, and the Shenzhen CSI 300 gained 2.53%, finishing the day at 4,044.57.</li>
<li>Hong Kong&#8217;s Hang Seng climbed 2.14% and closed the session at 21,006.97.</li>
</ul>
Eurozone at 05.30 AM ET
<ul>
<li>The European STOXX 50 index was up 0.05%.</li>
<li>Germany&#8217;s DAX declined 0.01%.</li>
<li>France&#8217;s CAC rose 0.04%.</li>
<li>U.K.'sU.K.&#8217;s FTSE 100 index traded higher by 0.25%.</li>
</ul>
Commodities at 05.30 AM ET
<ul>
<li>Crude Oil WTI was trading higher by 0.35% at $71.73/bbl, and Brent was up 0.36% at $75.33/bbl.</li>
<li>Oil prices stayed within a narrow range as markets awaited the U.S. presidential election, following a 2% rise after OPEC+ delayed a planned December production increase.</li>
<li>Natural Gas declined 0.36% to $2.771.</li>
<li>Gold was trading higher by 0.10% at $2,748.80, Silver gained 0.48% to $32.767, and Copper rose 0.85% to $4.4688.</li>
</ul>
U.S. Futures at 05.30 AM ET
Dow futures were up 0.13%, S&amp;P 500 futures gained 0.17%, and Nasdaq 100 Futures rose 0.27%.
Forex at 05.30 AM ET
<ul>
<li>The U.S. dollar index fell 0.12% to 103.77, the USD/JPY was up 0.05% to 152.20, and the USD/AUD declined 0.49% to 1.5110.</li>
<li>The dollar softened as election volatility spiked while traders awaited the Fed&#8217;s rate decision.</li>
</ul>
Photo by Pavel Bobrovskiy via Shutterstock

Asia

Emerging Markets

Eurozone

Futures

Commodities

Forex

ADIV

AGOV

ASHR

BBEU

BOIL

CQQQ

PowerShares DBmmodity Index Optimum Yield Diversified Fund

EEMA

FLAX

CurrencyShares British Pound Sterling Trust

IEMG

IEUR

KraneShares Trust KraneShares S&P Pan Asia Dividend Aristocrats Index ETF

KDIV

SPEM

USDU

PowerShares DB US Dollar Index Bullish Fund

On US Election Day, Asia Mostly In Green, Europe Mixed, Dollar Softens - Global Markets Today While US Slept

Gartner Raises FY24 Outlook: Sees Adjusted EPS Of $11.75 Vs. $11.68 Estimate (Prior View: $11.05), Projects Total Revenues Of $6.225B Vs. $6.23B Estimate (Prior View: $6.20B)

Oppenheimer analyst Jeff Jones maintained a Buy rating on Chemomab Therapeutics (CMMB – Research Report) today and set a price target of $13.00. Th...

Chemomab Therapeutics (CMMB) Gets a Buy from Oppenheimer

Maxim Group analyst Michael Okunewitch has maintained their bullish stance on CMMB stock, giving a Buy rating today. Michael Okunewitch has given h...

Chemomab Therapeutics: Strong Buy Rating on Robust Financials and Positive Clinical Trial Outcomes

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Chemomab Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/cmmb-stock-quote/">CMMB</a>) just reported results for the second quarter of 2024.<ul><li>Chemomab Therapeutics reported earnings per share of -26 cents.</li><li>The company did not report any revenue for the quarter.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div>	The post <a href="https://investorplace.com/earning-results/2024/08/cmmb-stock-earnings-chemomab-therapeutics-for-q2-of-2024/">CMMB Stock Earnings: Chemomab Therapeutics Reported Results for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

CMMB Stock Earnings: Chemomab Therapeutics Reported Results for Q2 2024

Chemomab Therapeutics (CMMB) has released an update. Chemomab Therapeutics Ltd. invites shareholders to a Special General Meeting on November 18, 2...

Chemomab Therapeutics Announces Shareholder Meeting

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Argenx Se (ARGX – Research Report), Chemomab Therape...

Wall Street Analysts Are Bullish on Top Healthcare Picks

ARGX

CMMB

Press Releases

Chemomab Therapeutics Announces Positive Phase 2 Trial Results: CM-101 Achieves Primary and Secondary Endpoints Demonstrating Anti-Fibrotic, Anti-Inflammatory and Anti-Cholestatic Effects in Patients with Primary Sclerosing Cholangitis

Financing

Chemomab Therapeutics Announces $10 Million Private Placement

Chemomab Therapeutics Regains Compliance With Nasdaq Minimum Bid Price Requirement

Chemomab Therapeutics Announces Closing of $10 Million Private Placement

Chemomab Therapeutics to Report Second Quarter 2024 Financial Results and Provide a Business Update

Chemomab Therapeutics Announces Second Quarter 2024 Financial Results and Provides Corporate Update

Chemomab Therapeutics to Present at September 2024 Investor Conferences

Chemomab Therapeutics to Present at October 2024 Investor Conferences

Chemomab Therapeutics Announces Late-Breaking Oral Presentation of CM-101 Phase 2 Results in Primary Sclerosing Cholangitis at AASLD The Liver Meeting® 2024

Comments

Chemomab Therapeutics

Chemomab Therapeutics (CMMB) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO